Pharmaceutical technology problems in the preparation of drugs for the treatment of cardiovascular diseases
Moldenhauer, H.
Die Pharmazie 34(8): 500-506
1979
ISSN/ISBN: 0031-7144 PMID: 538075 Document Number: 147408
Document emailed within 1 workday
Related Documents
Tsagareishvili, G.V.; Bashura, A.A.; Alekseeva, M.A.; Bashura, G.S. 2012: Rheologic properties of some pharmaceutical excipients in drug forms and cosmetic preparation technology Georgian Medical News 207: 57-62Halawa, B. 1981: Complications associated with sudden withdrawal of various drugs used in the treatment of cardiovascular diseases Wiadomosci Lekarskie 34(6): 491-495
Mazchenko, N.S.; Smirnova, N.S. 1984: Problems and errors in the diagnosis and treatment of suppurative-inflammatory diseases related to allergic reactions to drugs Khirurgiia 8: 102-104
Bohm, R.; Heinemann, L.; Schmidt, J.; Heinrich, K.; Richter, R.; Läuter, J. 1977: Use of a computer for the preparation of medical history screening in cardiovascular diseases Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 32(18): Suppl: 282-283
Zych, J.; Kostka, V. 1989: The position of the Czech Pharmaceutical Society on problems in the pharmaceutical services during reconstruction of the Czechoslovak health service Ceskoslovenska Farmacie 38(5): 193-194
Arkhipov, I.V.; Bagdat'ev, V.E.; Gel'fand, B.R.; Lapshina, I.I. 1983: Preoperative preparation and postoperative therapy of surgical patients with concomitant diseases of the cardiovascular system Anesteziologiia i Reanimatologiia 1: 9-12
Nishikawa, J.; Iio, M. 1984: Indication for angiography of the coronary and major vessels for the diagnosis of cardiovascular diseases. b. the present status of medical imaging technology--NMR Nihon Rinsho. Japanese Journal of Clinical Medicine 42(12): 2635-2638
Kuznetsov, G.P.; Lebedev, P.A. 1995: The clinical significance of selenium deficiency in patients from the Samara region with cardiovascular diseases and its correction with the preparation Selena Eksperimental'naia i Klinicheskaia Farmakologiia 58(5): 26-28
Chazov, E.I. 2002: Problems in primary and secondary prevention of cardiovascular diseases Terapevticheskii Arkhiv 74(9): 5-8
Tang, J.; Qin, Y.; Chen, G. 1997: Gene transfer DNA drugs directed into skeletal muscle and its uses in cardiovascular diseases Zhonghua Yi Xue Za Zhi 77(10): 799-800
Lozinskiĭ, L.G.; Venediktova, M.G.; Zakharova, G.I.; Sandomirskiĭ, B.L. 1986: Development of methods for research on the clinical pharmacology of drugs used in cardiovascular diseases Farmakologiia i Toksikologiia 49(5): 60-62
Allen, L.V. 1995: Drugs, devices and delivery considerations in parenteral pharmaceutical care, or, what are they doing with our drugs? PDA Journal of Pharmaceutical Science and Technology 49(6): 306-308
Heydel, E.; Pommerenke, G.; Wilken, J. 1980: Clinical and pharmaceutical observations on the drug treatment of periodontal diseases Stomatologie der DDR 30(9): 655-662
Weser, C.; Klessen, D. 1978: Strategy for the control of cardiovascular diseases in a metropolis (demonstrated by the Berlin concept of a unified system of care for patients with cardiovascular diseases) Zeitschrift für Arztliche Fortbildung 72(20): 967-971
Glasunov, I.S. 1985: Study of problems of epidemiology and prevention of cardiovascular diseases--twenty years of cooperation with the journal, Cor et Vasa Cor et Vasa 27(2-3): 147-152
Poliakov, I.V.; Petrova, N.G.; Chigireva, O.V. 1990: Problems of the organization of outpatient cardiac consultation services for patients with cardiovascular diseases in a large city Sovetskoe Zdravookhranenie 1990(2): 8-12
Fekete, P. 1993: Pharmaceutical technology of Grandaxin Acta Pharmaceutica Hungarica 63(2): 67-78
1999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
Metelitsa, V.I.; Ostrovskaia, T.P.; Duda, S.G.; Filatova, N.P.; Vygodin, V.A.; Mukhamedzhanova, G.F. 1994: The basic antihypertensive drugs for the long-term secondary prevention of cardiovascular diseases (the working group of the multicenter study Captopril and the Quality of Life) Terapevticheskii Arkhiv 66(9): 78-82
Hampel, R.; Meng, W.; Weber, A.; Meng, S.; Ventz, M. 1980: Problems of treatment with thyroid hormones. Thyroxin monotherapy or a T3/T4 combination preparation? Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 35(6): 258-261